http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36b958e106bf1459eb3c77089fbf9157
Outgoing Links
Predicate | Object |
---|---|
family-name | Rexhepaj |
name | Elton Rexhepaj |
given-name | Elton |
organization-name | Authors' Affiliations: 1Departments of Pathology, 3Radiation Oncology, 5Medicine, and 7Surgery, and 6Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco; 2University College Dublin School of Biomolecular and Biomedical Science, University College Dublin Conway Institute, Belfield, and 4National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin, Ireland; 8Center for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden; and 9Plexxikon Inc., Berkeley, California Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, SE-75185 Uppsala, Sweden, Department of Oncology, Uppsala University Hospital, SE-75185 Uppsala Sweden, Department of Proteomics, School of Biotechnology, AlbaNova University Center, KTH-Royal Institute of Technology, SE-10691 Stockholm, Sweden, and UCD School of Biomolecular and Biomedical Science, UCD, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland Science for Life Laboratory, Royal Institute of Technology (KTH), SE-17121 Solna, Sweden; Authors' Affiliations: 1Goodman Cancer Centre and 2Department of Microbiology and Immunology, McGill University; 3McGill Centre for Bioinformatics, Montreal, Quebec, Canada; 4Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; 5UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland; 6Center for Molecular Pathology, Department of Laboratory Medicine, Malmö University Hospital, Malmö, Sweden; and 7Department of Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 1UCD School of Biomolecular and Biomedical Science and Authors' Affiliations: 1Barts Cancer Institute, Queen Mary University of London; 2Cancer Research UK Bioinformatics and Biostatistics Service; 3Department of Pathology, Barts and the London NHS Trust, Royal London Hospital, London, United Kingdom; 4Ortho Biotech Oncology R&D Division of Centocor, Radnor, Pennsylvania; 5OrthoBio R&D Oncology, Division of Centocor BV, Leiden, the Netherlands; 6Clinical and Experimental Pharmacology, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom; 7UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland; and 8Centre for Molecular Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, Malmö, Sweden Sanofi Aventis, Chilly‐Mazarin Essone France |
Incoming Links
Total number of triples: 40.